Inmunoglobulinas equinas fragmentos F(ab')2 (suero equino hiperinmune) en COVID-19

Instituto de Efectividad Clínica y Sanitaria.
Buenos Aires; IECS; 4 feb. 2021.
No convencional en Español | LILACS, BRISA | ID: biblio-1148055

Documentos relacionados

  1. Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
  2. Management of post-mortem examination in SARS-CoV-19 infections.
  3. Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities.
  4. Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic.
  5. Comment on "Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series."Author reply.
  6. Comment on "Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series".
  7. Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series.
  8. [Living with an ongoing crisis - insights from the coronavirus - SARS-CoV].
  9. Coronavirus: time to re-imagine academic publishing.
  10. Coronavirus outbreak: what's next?